Aptorum Group Limited Reports 2023 Fiscal Year End Financial Results and Provides Business Update

Aptorum Group Limited , a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announced financial...

Related Keywords

Singapore ,British Virgin Islands ,Ian Huen ,Aptorum Group Form ,Singapore Agency For Science ,Technologies Pte Ltd ,Group Holding ,Aptorum Group Limited Nasdaq ,Daptorum Group ,Aptorum Group Or We ,Aptorum Group Limited ,Chief Executive Officer ,Executive Director ,Holding Limited ,Merger Agreement ,Ordinary Shares ,Group Limited ,Accelerate Technologies Pte Ltd ,Securities Litigation Reform Act ,Years Ended December ,Markets ,